Literature DB >> 15079026

Behavioral symptoms in mild cognitive impairment.

H Feldman1, P Scheltens, E Scarpini, N Hermann, P Mesenbrink, L Mancione, S Tekin, R Lane, S Ferris.   

Abstract

The authors investigated neuropsychiatric symptoms in mild cognitive impairment (MCI) from baseline data of the Investigation in the Delay to Diagnosis of AD with Exelon (InDDEx) study (n = 1,010). Neuropsychiatric symptoms were reported in 59% of subjects (Neuropsychiatric Inventory [NPI]). NPI+ subjects had significantly greater impairment on global, cognitive, and functional scores than NPI- subjects. The presence of neuropsychiatric symptoms appears to be a marker of MCI severity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15079026     DOI: 10.1212/01.wnl.0000118301.92105.ee

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  44 in total

Review 1.  REVIEW: Apathy diagnosis, assessment, and treatment in Alzheimer's disease.

Authors:  Philippe H Robert; Emmanuel Mulin; Patrick Malléa; Renaud David
Journal:  CNS Neurosci Ther       Date:  2010-10       Impact factor: 5.243

2.  Mild behavioral impairment and risk of dementia: a prospective cohort study of 358 patients.

Authors:  Fernando E Taragano; Ricardo F Allegri; Hugo Krupitzki; Diego R Sarasola; Cecilia M Serrano; Leandro Loñ; Constantine G Lyketsos
Journal:  J Clin Psychiatry       Date:  2009-03-24       Impact factor: 4.384

3.  Neuropsychiatric symptoms as early manifestations of emergent dementia: Provisional diagnostic criteria for mild behavioral impairment.

Authors:  Zahinoor Ismail; Eric E Smith; Yonas Geda; David Sultzer; Henry Brodaty; Gwenn Smith; Luis Agüera-Ortiz; Rob Sweet; David Miller; Constantine G Lyketsos
Journal:  Alzheimers Dement       Date:  2015-06-18       Impact factor: 21.566

4.  Behavioral symptoms in community-dwelling elderly Nigerians with dementia, mild cognitive impairment, and normal cognition.

Authors:  Olusegun Baiyewu; Fred W Unverzagt; Adesola Ogunniyi; Valerie Smith-Gamble; Oye Gureje; Kathleen A Lane; Sujuan Gao; Kathleen S Hall; Hugh C Hendrie
Journal:  Int J Geriatr Psychiatry       Date:  2012-03-02       Impact factor: 3.485

5.  The Neuropsychiatric Inventory-Clinician rating scale (NPI-C): reliability and validity of a revised assessment of neuropsychiatric symptoms in dementia.

Authors:  Kate de Medeiros; P Robert; S Gauthier; F Stella; A Politis; J Leoutsakos; F Taragano; J Kremer; A Brugnolo; A P Porsteinsson; Y E Geda; H Brodaty; G Gazdag; J Cummings; C Lyketsos
Journal:  Int Psychogeriatr       Date:  2010-07-01       Impact factor: 3.878

Review 6.  Rivastigmine for Alzheimer's disease.

Authors:  Jacqueline S Birks; Lee Yee Chong; John Grimley Evans
Journal:  Cochrane Database Syst Rev       Date:  2015-09-22

7.  Do MCI criteria in drug trials accurately identify subjects with predementia Alzheimer's disease?

Authors:  P J Visser; P Scheltens; F R J Verhey
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-10       Impact factor: 10.154

8.  Education and Cognitive Decline: An Integrative Analysis of Global Longitudinal Studies of Cognitive Aging.

Authors:  Sean A P Clouston; Dylan M Smith; Soumyadeep Mukherjee; Yun Zhang; Wei Hou; Bruce G Link; Marcus Richards
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  2020-08-13       Impact factor: 4.077

9.  Neuropsychiatric symptoms in mild cognitive impairment: differences by subtype and progression to dementia.

Authors:  Emily R Edwards; Adam P Spira; Deborah E Barnes; Kristine Yaffe
Journal:  Int J Geriatr Psychiatry       Date:  2009-07       Impact factor: 3.485

10.  Caregiver support service needs for patients with mild cognitive impairment and Alzheimer disease.

Authors:  Kelly A Ryan; Annie Weldon; Nicole M Huby; Carol Persad; Arijit K Bhaumik; Judith L Heidebrink; Nancy Barbas; Nancy Staffend; Lindsay Franti; Bruno Giordani
Journal:  Alzheimer Dis Assoc Disord       Date:  2010 Apr-Jun       Impact factor: 2.703

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.